JAZZ PHARMACEUTICALS INNOVATION CENTER

DIGITAL ASSET DESCRIPTION The RWA tied to 3170 Porter Drive, Palo Alto, CA 94304 represents ownership exposure to a major research and innovation facility associated with Jazz Pharmaceuticals, a biotechnology company focused on developing therapies for serious and often underserved medical conditions. Located within the innovation ecosystem of Silicon Valley, this campus served as a center for scientific research, drug development, and biopharmaceutical operations. What makes this asset significant is its connection to an institution that built its reputation by pursuing challenges frequently overlooked by larger segments of the healthcare industry. Rather than concentrating solely on broad-market therapies, Jazz became known for addressing complex diseases in areas such as oncology, neuroscience, sleep disorders, and rare conditions where treatment options were often limited. The blockchain connection is direct. Both biotechnology and blockchain create value by solving problems that traditional systems struggle to address. One seeks solutions for complex medical conditions, while the other creates new frameworks for trust, ownership, and verification. As a blockchain-based real-world asset, 3170 Porter Drive represents verifiable exposure to a biotechnology institution focused on expanding treatment possibilities for patients facing some of medicine's most difficult challenges. The significance of this address is not the building itself. The significance is its connection to a company that chose to pursue medical problems that many others considered too difficult, too specialized, or too small to prioritize. ## Archived & Preserved by Jacob Alan Ervin Lovaas🇺🇸🎩 June 7, 2026